Disparities in bone density measurement history and osteoporosis medication utilisation in Swiss women: results from the Swiss Health Survey 2007

<p>Abstract</p> <p>Background</p> <p>Although factors associated with the utilisation of bone density measurement (BDM) and osteoporosis treatment have been regularly assessed in the US and Canada, they have not been effectively analysed in European countries. This stud...

Full description

Bibliographic Details
Main Authors: Born Rita, Zwahlen Marcel
Format: Article
Language:English
Published: BMC 2013-01-01
Series:BMC Musculoskeletal Disorders
Subjects:
Online Access:http://www.biomedcentral.com/1471-2474/14/10
id doaj-0d9df2322f5a42d6b53873d2fdfd5450
record_format Article
spelling doaj-0d9df2322f5a42d6b53873d2fdfd54502020-11-24T21:04:43ZengBMCBMC Musculoskeletal Disorders1471-24742013-01-011411010.1186/1471-2474-14-10Disparities in bone density measurement history and osteoporosis medication utilisation in Swiss women: results from the Swiss Health Survey 2007Born RitaZwahlen Marcel<p>Abstract</p> <p>Background</p> <p>Although factors associated with the utilisation of bone density measurement (BDM) and osteoporosis treatment have been regularly assessed in the US and Canada, they have not been effectively analysed in European countries. This study assessed factors associated with the utilisation of BDM and osteoporosis medication (OM) in Switzerland.</p> <p>Methods</p> <p>The Swiss Health Survey 2007 data included self-reported information on BDM and OM for women aged 40 years and older who were living in private households. Multivariable logistic regression analysis was used to identify sociodemographic, socioeconomic, healthcare-related and osteoporosis risk factors associated with BDM and OM utilisation.</p> <p>Results</p> <p>The lifetime prevalence of BDM was 25.6% (95% CI: 24.3-26.9%) for women aged 40 years and older. BDM utilisation was associated with most sociodemographic factors, all the socioeconomic and healthcare-related factors, and with major osteoporosis risk factors analysed. The prevalence of current OM was 7.8% (95% CI: 7.0-8.6%) and it was associated with some sociodemographic and most healthcare-related factors but only with one socioeconomic factor.</p> <p>Conclusions</p> <p>In Swiss women, ever having had a BDM and current OM were low and utilisation disparities exist according to sociodemographic, socioeconomic and healthcare-related factors. This might foster further health inequalities. The reasons for these findings should be addressed in further studies of the elderly women, including those living in institutions.</p> http://www.biomedcentral.com/1471-2474/14/10Bone density measurementOsteoporosisMedicationSociodemographicSocioeconomicHealth survey
collection DOAJ
language English
format Article
sources DOAJ
author Born Rita
Zwahlen Marcel
spellingShingle Born Rita
Zwahlen Marcel
Disparities in bone density measurement history and osteoporosis medication utilisation in Swiss women: results from the Swiss Health Survey 2007
BMC Musculoskeletal Disorders
Bone density measurement
Osteoporosis
Medication
Sociodemographic
Socioeconomic
Health survey
author_facet Born Rita
Zwahlen Marcel
author_sort Born Rita
title Disparities in bone density measurement history and osteoporosis medication utilisation in Swiss women: results from the Swiss Health Survey 2007
title_short Disparities in bone density measurement history and osteoporosis medication utilisation in Swiss women: results from the Swiss Health Survey 2007
title_full Disparities in bone density measurement history and osteoporosis medication utilisation in Swiss women: results from the Swiss Health Survey 2007
title_fullStr Disparities in bone density measurement history and osteoporosis medication utilisation in Swiss women: results from the Swiss Health Survey 2007
title_full_unstemmed Disparities in bone density measurement history and osteoporosis medication utilisation in Swiss women: results from the Swiss Health Survey 2007
title_sort disparities in bone density measurement history and osteoporosis medication utilisation in swiss women: results from the swiss health survey 2007
publisher BMC
series BMC Musculoskeletal Disorders
issn 1471-2474
publishDate 2013-01-01
description <p>Abstract</p> <p>Background</p> <p>Although factors associated with the utilisation of bone density measurement (BDM) and osteoporosis treatment have been regularly assessed in the US and Canada, they have not been effectively analysed in European countries. This study assessed factors associated with the utilisation of BDM and osteoporosis medication (OM) in Switzerland.</p> <p>Methods</p> <p>The Swiss Health Survey 2007 data included self-reported information on BDM and OM for women aged 40 years and older who were living in private households. Multivariable logistic regression analysis was used to identify sociodemographic, socioeconomic, healthcare-related and osteoporosis risk factors associated with BDM and OM utilisation.</p> <p>Results</p> <p>The lifetime prevalence of BDM was 25.6% (95% CI: 24.3-26.9%) for women aged 40 years and older. BDM utilisation was associated with most sociodemographic factors, all the socioeconomic and healthcare-related factors, and with major osteoporosis risk factors analysed. The prevalence of current OM was 7.8% (95% CI: 7.0-8.6%) and it was associated with some sociodemographic and most healthcare-related factors but only with one socioeconomic factor.</p> <p>Conclusions</p> <p>In Swiss women, ever having had a BDM and current OM were low and utilisation disparities exist according to sociodemographic, socioeconomic and healthcare-related factors. This might foster further health inequalities. The reasons for these findings should be addressed in further studies of the elderly women, including those living in institutions.</p>
topic Bone density measurement
Osteoporosis
Medication
Sociodemographic
Socioeconomic
Health survey
url http://www.biomedcentral.com/1471-2474/14/10
work_keys_str_mv AT bornrita disparitiesinbonedensitymeasurementhistoryandosteoporosismedicationutilisationinswisswomenresultsfromtheswisshealthsurvey2007
AT zwahlenmarcel disparitiesinbonedensitymeasurementhistoryandosteoporosismedicationutilisationinswisswomenresultsfromtheswisshealthsurvey2007
_version_ 1716770057016573952